Company / PP&E (Net)
MARAVAI LIFESCIENCES HOLDINGS, INC. PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$151.5M
FY2025
5-year range
$46.3M / $164.5M
FY2021-FY2025
Trend
-7.9%
vs FY2024
Sector context
#33 of 193
Health Care
What the data says
MARAVAI LIFESCIENCES HOLDINGS, INC.'s pp&e (net) of $151M is higher than 83% of companies in the Health Care sector (FY2025). Declined from $163M to $151M over the past 2 years.
Based on SEC 10-K filings.
$151M in FY2025 with a 5-year CAGR of +8.4%. Top quartile in the Health Care sector.
Declined from $163M to $151M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +42.2%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 193This company $151.5M Sector average $777.6M
▼
-80.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.4%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 7.9% year-over-year.
- Ranks #33 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $151.5M | -7.9% |
| FY2024 | $164.5M | +1.0% |
| FY2023 | $162.9M | +209.1% |
| FY2022 | $52.7M | +13.7% |
| FY2021 | $46.3M | -54.3% |
| FY2020 | $101.3M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026